37 results
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
9 May 24
Akebia Therapeutics Reports First Quarter 2024 Financial Results
7:03am
%).
SPECIFIC POPULATIONS
Exhibit 99.1
Pregnancy and Lactation: There are no available data on AURYXIA use in pregnant women to inform a drug-associated risk … of major birth defects and miscarriage. However, an overdose of iron in pregnant women may carry a risk for spontaneous abortion, gestational diabetes
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
14 Mar 24
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:18pm
%) and hyperkalemia (5%).
SPECIFIC POPULATIONS
Pregnancy and Lactation: There are no available data on AURYXIA use in pregnant women to inform a drug-associated … risk of major birth defects and miscarriage. However, an overdose of iron in pregnant women may carry a risk for spontaneous abortion, gestational
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
8 Nov 23
Akebia Therapeutics Reports Third Quarter 2023 Financial Results
7:33am
: There are no available data on AURYXIA use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. However … , an overdose of iron in pregnant women may carry a risk for spontaneous abortion, gestational diabetes and fetal malformation. Data from rat studies have shown
8-K
EX-99.1
y3o0lox ct26
26 Sep 23
Akebia Announces Approval of Vafseo® (vadadustat) in Australia and Provides Commercial Update
4:47pm
8-K
EX-99.1
gd2gy009aiye1vv uwxh
25 Aug 23
Akebia Therapeutics Reports Second Quarter 2023 Financial Results
8:14am
8-K
EX-99.1
31xvueoi1gacllewhs2
11 Aug 23
Akebia Therapeutics Provides Update on Form 10-Q Filing
7:35am
8-K
EX-99.1
iypmsmc9vk20qh9uvyg
8 May 23
Akebia Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
7:41am
8-K
EX-99.1
xmrgp
3 Nov 22
Akebia Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
4:33pm
8-K
EX-99.1
r3kakjeuxbgxzss2r0
4 Aug 22
Akebia Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
4:14pm
8-K
EX-99.1
s75rh5
9 May 22
Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update
4:11pm
8-K
EX-99.1
siqk5iomgxg
1 Mar 22
Akebia Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights
4:04pm
8-K
EX-99.1
8u8r on1m
4 Nov 21
Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:10am
8-K
EX-99.1
nxxk7lmp 673qk
9 Sep 21
Regulation FD Disclosure
6:13am
8-K
EX-99.1
o9molyvf
5 Aug 21
Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:06am
8-K
EX-99.1
dms9zi0xiw60jkorlm13
10 May 21
Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:11am
8-K
EX-99.1
akg2h geumc
25 Feb 21
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides
8:04am